Your browser doesn't support javascript.
loading
Efficacy and safety of alirocumab in insulin-treated individuals with type 1 or type 2 diabetes and high cardiovascular risk: The ODYSSEY DM-INSULIN randomized trial.
Leiter, Lawrence A; Cariou, Bertrand; Müller-Wieland, Dirk; Colhoun, Helen M; Del Prato, Stefano; Tinahones, Francisco J; Ray, Kausik K; Bujas-Bobanovic, Maja; Domenger, Catherine; Mandel, Jonas; Samuel, Rita; Henry, Robert R.
Afiliação
  • Leiter LA; Li Ka Shing Knowledge Institute, St. Michael's Hospital, University of Toronto, Toronto, Ontario, Canada.
  • Cariou B; Department of Endocrinology, l'institut du thorax, CHU Nantes, INSERM, CNRS, UNIV Nantes, Nantes, France.
  • Müller-Wieland D; Department of Internal Medicine I, University Hospital RWTH Aachen, Aachen, Germany.
  • Colhoun HM; University of Edinburgh, Edinburgh, UK.
  • Del Prato S; Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
  • Tinahones FJ; Hospital Virgen de la Victoria, CIBERobn, Málaga University, Málaga, Spain.
  • Ray KK; Department of Primary Care and Public Health, School of Public Health, Imperial College London, London, UK.
  • Bujas-Bobanovic M; Sanofi, Paris, France.
  • Domenger C; Sanofi, Gentilly, France.
  • Mandel J; Sanofi, Chilly-Mazarin, France.
  • Samuel R; IviData Stats, Levallois-Perret, Paris, France.
  • Henry RR; Regeneron Pharmaceuticals, Inc., Tarrytown, New York.
Diabetes Obes Metab ; 19(12): 1781-1792, 2017 12.
Article em En | MEDLINE | ID: mdl-28905478
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 1 / Diabetes Mellitus Tipo 2 / Hipercolesterolemia / Hipoglicemiantes / Insulina / Anticorpos Monoclonais / Anticolesterolemiantes Idioma: En Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 1 / Diabetes Mellitus Tipo 2 / Hipercolesterolemia / Hipoglicemiantes / Insulina / Anticorpos Monoclonais / Anticolesterolemiantes Idioma: En Ano de publicação: 2017 Tipo de documento: Article